Our group's collaborative work with NTU on antiviral nanoparticle vaccine technology received the National Innovation Award (國家新創獎）. Congratulations!
Dr. Hu received the prestigious Chen-Yuan Lee Young Investigator Award (李鎮源教授醫學研究青年學者獎).
Sherry received the Best Poster Award at the TIGP-MMP retreat for her work on nanoparticle-based universal influenza vaccine. Congratulations Sherry!
Saborni passed her thesis defense. Congratulations Dr. Chattopadhyay!
Saborni's paper on STING agonist nanoshell-mediated synthetic immunogenic cell death for anticancer chemo-immunotherapy is accepted for publication in Nano Letters. Congratulations! [Link]
Dr. Hu's perspective article on COVID-19 vaccine development is featured in Scientific American. [Link]
Dr. Hu is named a Highly Cited Researcher for 2019 by the Web of Science Group.
Our lab's work on a precision nanoparticle vaccine platform is selected as the highlight technology in the 2019 Future Tech Expo organized by the Ministry of Science and Technology. Congratulations!
Seny Liu received the Excellent Poster Award at the 16th Symposium of the Frontiers of Biomedical Sciences. Congratulations!
Dr. Hu received the 15th Young Scholar Award from the TienTe Lee Biomedical Foundation.
Our work on gelated cell technology for anticancer T cell expansion received the Best Poster Award at the 2019 Gordon Research Conference on cancer nanotechnology. Congratulations!
Seny Liu obtained her Ph.D. with the highest honors (#1 rank) from her graduating class. Congratulations Dr. Liu.
Che-Ming Jack Hu (胡哲銘）
Associate Research Fellow
Institute of Biomedical Sciences, Academia Sinica
Dr. Jack Hu recevied his Ph.D. in Biomedical Engineering from the University of California, San Diego in 2011 and recevied postdoctoral trainings in the Nanoengineering Department of UCSD. He holds a B.S. degree in Biomedical Engineering with minors in Mechanical Engineering and Electrical Engineering from UC Berkeley.
Nanotechnology in medicine has shown tremendous value in drug delivery and vaccine preparations, where pharmacokinetics and immune activation can be finely tuned via rational nanomaterials engineering. The research focus of the laboratory is to develop novel therapeutic nanomaterials with an emphasis toward clinical translation. We seek to adopt an engineering approach to improve treatments for major diseases including cardiovascular disease, cancer, and infectious disease.